Cargando…
Self-efficacy and self-management strategies in acute intermittent porphyria
BACKGROUND: Acute intermittent porphyria (AIP) is an inherited metabolic disease with low clinical penetrance caused by mutations in the hydroxymethylbilane (HMBS) gene. Although most patients experience little or no symptoms, serious attacks may include excruciating pain, severe electrolyte disturb...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607542/ https://www.ncbi.nlm.nih.gov/pubmed/31269991 http://dx.doi.org/10.1186/s12913-019-4285-9 |
_version_ | 1783432115463913472 |
---|---|
author | Hammersland, Marte H. Aarsand, Aasne K. Sandberg, Sverre Andersen, Janice |
author_facet | Hammersland, Marte H. Aarsand, Aasne K. Sandberg, Sverre Andersen, Janice |
author_sort | Hammersland, Marte H. |
collection | PubMed |
description | BACKGROUND: Acute intermittent porphyria (AIP) is an inherited metabolic disease with low clinical penetrance caused by mutations in the hydroxymethylbilane (HMBS) gene. Although most patients experience little or no symptoms, serious attacks may include excruciating pain, severe electrolyte disturbances, paresis, and respiratory failure. Several drugs and lifestyle factors are potential attack inducers and avoiding known triggers is important to avoid symptomatic disease in both patients and genetically predisposed carriers. Our aim in this study was to describe self-efficacy and self-management strategies in self-reported symptomatic and asymptomatic HMBS mutation carriers, and to elucidate motives for predictive genetic testing. METHODS: This is a cross-sectional retrospective survey with postal questionnaires. We received responses from 140 HMBS carriers for the general self-efficacy scale (GSES), study-specific questions about symptoms, self-management strategies and motives for genetic testing and satisfaction with the genetic counseling scale (SCS). RESULTS: The results indicated high levels of self-efficacy in these Norwegian HMBS mutation carriers. Both self-reported symptomatic and asymptomatic cases recorded changes in behavior after diagnosis, such as avoiding possible triggering drugs and aspiring recommended eating habits. They were in general satisfied with the genetic counseling they had received. The possibility to prevent disease and learn about the risk of their children was their most important motives to undergo genetic testing. CONCLUSIONS: This study indicates that continuing to provide information, counseling and education is beneficial in AIP, and that HMBS mutation carriers, both those self-assessed as asymptomatic and as symptomatic, are using their knowledge to avoid triggering factors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-019-4285-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6607542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66075422019-07-12 Self-efficacy and self-management strategies in acute intermittent porphyria Hammersland, Marte H. Aarsand, Aasne K. Sandberg, Sverre Andersen, Janice BMC Health Serv Res Research Article BACKGROUND: Acute intermittent porphyria (AIP) is an inherited metabolic disease with low clinical penetrance caused by mutations in the hydroxymethylbilane (HMBS) gene. Although most patients experience little or no symptoms, serious attacks may include excruciating pain, severe electrolyte disturbances, paresis, and respiratory failure. Several drugs and lifestyle factors are potential attack inducers and avoiding known triggers is important to avoid symptomatic disease in both patients and genetically predisposed carriers. Our aim in this study was to describe self-efficacy and self-management strategies in self-reported symptomatic and asymptomatic HMBS mutation carriers, and to elucidate motives for predictive genetic testing. METHODS: This is a cross-sectional retrospective survey with postal questionnaires. We received responses from 140 HMBS carriers for the general self-efficacy scale (GSES), study-specific questions about symptoms, self-management strategies and motives for genetic testing and satisfaction with the genetic counseling scale (SCS). RESULTS: The results indicated high levels of self-efficacy in these Norwegian HMBS mutation carriers. Both self-reported symptomatic and asymptomatic cases recorded changes in behavior after diagnosis, such as avoiding possible triggering drugs and aspiring recommended eating habits. They were in general satisfied with the genetic counseling they had received. The possibility to prevent disease and learn about the risk of their children was their most important motives to undergo genetic testing. CONCLUSIONS: This study indicates that continuing to provide information, counseling and education is beneficial in AIP, and that HMBS mutation carriers, both those self-assessed as asymptomatic and as symptomatic, are using their knowledge to avoid triggering factors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-019-4285-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-03 /pmc/articles/PMC6607542/ /pubmed/31269991 http://dx.doi.org/10.1186/s12913-019-4285-9 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Hammersland, Marte H. Aarsand, Aasne K. Sandberg, Sverre Andersen, Janice Self-efficacy and self-management strategies in acute intermittent porphyria |
title | Self-efficacy and self-management strategies in acute intermittent porphyria |
title_full | Self-efficacy and self-management strategies in acute intermittent porphyria |
title_fullStr | Self-efficacy and self-management strategies in acute intermittent porphyria |
title_full_unstemmed | Self-efficacy and self-management strategies in acute intermittent porphyria |
title_short | Self-efficacy and self-management strategies in acute intermittent porphyria |
title_sort | self-efficacy and self-management strategies in acute intermittent porphyria |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607542/ https://www.ncbi.nlm.nih.gov/pubmed/31269991 http://dx.doi.org/10.1186/s12913-019-4285-9 |
work_keys_str_mv | AT hammerslandmarteh selfefficacyandselfmanagementstrategiesinacuteintermittentporphyria AT aarsandaasnek selfefficacyandselfmanagementstrategiesinacuteintermittentporphyria AT sandbergsverre selfefficacyandselfmanagementstrategiesinacuteintermittentporphyria AT andersenjanice selfefficacyandselfmanagementstrategiesinacuteintermittentporphyria |